Announcement

Collapse
No announcement yet.

InVivo Therapeutics Reports First Quarter 2011 Financial Results

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    InVivo Therapeutics Reports First Quarter 2011 Financial Results

    InVivo Therapeutics Reports First Quarter 2011 Financial Results
    InVivo Therapeutics (NVIV.OB), a medical device company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the first quarter 2011.

    For the three months ended March 31, 2011, the Company reported a net loss of $1,278,000, or $.02 per share, compared to a net loss of $454,000, or $.02 per share, for the quarter ended March 31, 2010. Operating expenses increased by $1,018,000 in the first quarter of 2011 as compared to the prior year as the Company made investments to expand infrastructure and capabilities to support a planned human clinical trial, and incurred costs associated with public company practices. The Company ended the first quarter of 2011 with $6,864,000 in cash.

    read...
    http://www.thestreet.com/story/11119...l-results.html

    #2
    This is an impressively low burn rate.

    Wise.

    Originally posted by manouli View Post
    InVivo Therapeutics Reports First Quarter 2011 Financial Results
    InVivo Therapeutics (NVIV.OB), a medical device company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the first quarter 2011.

    For the three months ended March 31, 2011, the Company reported a net loss of $1,278,000, or $.02 per share, compared to a net loss of $454,000, or $.02 per share, for the quarter ended March 31, 2010. Operating expenses increased by $1,018,000 in the first quarter of 2011 as compared to the prior year as the Company made investments to expand infrastructure and capabilities to support a planned human clinical trial, and incurred costs associated with public company practices. The Company ended the first quarter of 2011 with $6,864,000 in cash.

    read...
    http://www.thestreet.com/story/11119...l-results.html

    Comment

    Working...
    X